help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-129-2-582
Endocrinology Vol. 129, No. 2 582-590
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SANDY, J. R.
Right arrow Articles by FARNDALE, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SANDY, J. R.
Right arrow Articles by FARNDALE, R. W.

Leukotriene B4 Increases Intracellular Calcium Concentration and Phosphoinositide Metabolism in Mouse Osteoblasts via Cyclic Adenosine 3', 5'-Monophosphate-Independent Pathways*

JONATHAN R. SANDY, MURRAY C. MEIKLE, B. RICHARD MARTIN and RICHARD W. FARNDALE

Strangeways Research Laboratory Wort's Causeway, Cambridge CB1 4RN
Cambridge University Biochemistry Department Cambridge CB2 1QW, United Kingdom

Address correspondence and reprint requests to: Dr. R. W. Farndale, Cambridge University Biochemistry Department, Tennis Court Road, Cambridge CB2 1QW, United Kingdom.

Abstract

Leukotriene B4 is one of a number of agents which stimulate bone resorption by acting on osteoblasts. Some agonists, such as PTH or prostaglandins, are known to activate adenylate cyclase in osteoblasts, whereas others, such as vitamin D3, have no effect on adenylate cyclase. Recent evidence suggests that both classes of agonist may raise the intracellular calcium concentration, although the relative importance for bone resorption of calcium mobilization and adenylate cyclase activity in the osteoblast is not clear. Here it is shown 1) that leukotriene B4 does not activate but may be inhibitory toward adenylate cyclase in intact osteoblasts or membrane preparations, 2) that leukotriene B4 causes an elevation of intracellular calcium levels in osteoblast monolayers, 3) leukotriene B4 rapidly activates phosphatidylinositol bisphosphate breakdown in osteoblast membranes and intact osteoblasts, and 4) that leukotriene B4 stimulates phosphatidylinositol kinase activity concurrently with phosphoinositidase C in intact osteoblasts over a similar timescale. These results suggest that leukotriene B4 may increase the concentration of intracellular calcium in osteoblasts by stimulating phosphoinositide turnover, and support the proposal that calcium signaling rather than activation of adenylate cyclase in osteoblasts may be of overriding importance in the regulation of bone resorption.

Footnotes

* This work was supported by Medical Research Council grants (to J.R.S., R.W.F., and M.C.M.). Dr. Meikle is also supported by the Arthritis and Rheumatism Council and Dr. Farndale by CORDA, the heart charity.

Received December 3, 1990.




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Traianedes, M. R. Dallas, I. R. Garrett, G. R. Mundy, and L. F. Bonewald
5-Lipoxygenase Metabolites Inhibit Bone Formation in Vitro
Endocrinology, July 1, 1998; 139(7): 3178 - 3184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society